Skip to content
Brand AI

Helixmith

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2019

    Goldman Sachs faces backlash over Helixmith outlook change

    Goldman Sachs faced backlash from Helixmith and individual investors after changing its outlook on the Korean biopharmaceutical firm and sharply lowering its target price. Some investors suspected the change was aimed at facilitating short selling; the article presents this as suspicion, not an established finding.

    Source